Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial
(Q74453880)
scientific article published on 01 September 2001
scientific article published on 01 September 2001
Language:
other details
description | scientific article published on 01 September 2001 |
External Links
(P356) |
10.1200/JCO.2001.19.17.3771
|
(P698) |
11533101
|